FDA Renews Pinnacle 21 as Software Provider for DataFit
Pinnacle 21 announced today that it has been selected to provide custom software and related services to support the FDA’s DataFit program, which serves to expedite the new drug application process. - September 26, 2015
Pinnacle 21 CEO Max Kanevsky Named to PharmaVOICE 100
Pinnacle 21 announced today that its president & CEO, Max Kanevsky, has been named to the prestigious PharmaVOICE 100 list of the most innovative and influential people in the life-sciences industry. - August 07, 2015
Press Releases 1 - 2 of 2